# Randomized Trial of Maternal Progesterone Therapy

> **NCT02133573** · PHASE2 · COMPLETED · sponsor: **Children's Hospital of Philadelphia** · enrollment: 102 (actual)

## Conditions studied

- Congenital Heart Disease
- Periventricular Leucomalacia
- Brain Development
- Cardiac Surgery
- Neurodevelopmental Disability
- Fetal Neuroprotection

## Interventions

- **DRUG:** Progesterone
- **DRUG:** Vaginal lubricant

## Key facts

- **NCT ID:** NCT02133573
- **Lead sponsor:** Children's Hospital of Philadelphia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2021-11
- **Final completion:** 2021-11
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2023-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02133573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02133573, "Randomized Trial of Maternal Progesterone Therapy". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02133573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*